Select Medical (NYSE:SEM) Downgraded to “Hold” Rating by StockNews.com

by · The Cerbat Gem

StockNews.com cut shares of Select Medical (NYSE:SEM – Free Report) from a buy rating to a hold rating in a research note published on Tuesday.

SEM has been the subject of several other reports. Benchmark restated a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a research note on Friday, November 1st. Royal Bank of Canada raised their price objective on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday. Finally, Bank of America started coverage on Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price objective on the stock. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $40.75.

Check Out Our Latest Analysis on SEM

Select Medical Stock Up 1.9 %

SEM stock opened at $37.21 on Tuesday. The company has a market cap of $4.82 billion, a price-to-earnings ratio of 17.39, a P/E/G ratio of 2.09 and a beta of 1.42. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The business’s 50-day moving average is $34.31 and its two-hundred day moving average is $34.21. Select Medical has a fifty-two week low of $21.28 and a fifty-two week high of $40.50.

Select Medical (NYSE:SEM – Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. During the same quarter in the prior year, the business earned $0.46 EPS. The business’s quarterly revenue was up 5.7% on a year-over-year basis. As a group, analysts forecast that Select Medical will post 2.15 earnings per share for the current year.

Select Medical Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 1.34%. The ex-dividend date of this dividend is Wednesday, November 13th. Select Medical’s dividend payout ratio is currently 23.36%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Hexagon Capital Partners LLC raised its position in shares of Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after buying an additional 645 shares during the last quarter. Transcendent Capital Group LLC bought a new stake in Select Medical in the 2nd quarter valued at $35,000. Canada Pension Plan Investment Board purchased a new stake in Select Medical in the 2nd quarter worth $39,000. Fidelis Capital Partners LLC bought a new position in shares of Select Medical during the 1st quarter valued at about $47,000. Finally, DekaBank Deutsche Girozentrale purchased a new position in shares of Select Medical during the second quarter valued at about $60,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

About Select Medical

(Get Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Read More